Conference Coverage

Advances in ankylosing spondylitis hailed as rheumatology’s story of the year

Publish date: March 9, 2020

 

REPORTING FROM RWCS 2020

Pages

Recommended Reading

Retention rates comparable for biosimilars, original drug in spondyloarthritis
Journal of Clinical Outcomes Management
Quality standards aim to improve worldwide spondyloarthritis care
Journal of Clinical Outcomes Management
Flu vaccine succeeds in TNF inhibitor users
Journal of Clinical Outcomes Management
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
Journal of Clinical Outcomes Management
FDA approves Taltz for treatment of ankylosing spondylitis
Journal of Clinical Outcomes Management
Cannabidiol may interact with rheumatologic drugs
Journal of Clinical Outcomes Management
Consider centralized pain in patients with rheumatic disease
Journal of Clinical Outcomes Management
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Journal of Clinical Outcomes Management
New guideline offers recommendations for reproductive health in patients with rheumatic diseases
Journal of Clinical Outcomes Management